309 related articles for article (PubMed ID: 22628080)
1. Concurrent treatment with BCNU and Gamma Knife radiosurgery in the rat malignant glioma model.
Cho KT; Kim DG; Paek SH; Chung HT; Jung HW; Park HW
J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):132-41. PubMed ID: 22628080
[TBL] [Abstract][Full Text] [Related]
2. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.
Tsao MN; Mehta MP; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):47-55. PubMed ID: 16111571
[TBL] [Abstract][Full Text] [Related]
3. Effects of Gamma Knife surgery on C6 glioma in combination with adenoviral p53 in vitro and in vivo.
Xu D; Jia Q; Li Y; Kang C; Pu P
J Neurosurg; 2006 Dec; 105 Suppl():208-13. PubMed ID: 18503358
[TBL] [Abstract][Full Text] [Related]
4. The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine.
Selker RG; Shapiro WR; Burger P; Blackwood MS; Arena VC; Gilder JC; Malkin MG; Mealey JJ; Neal JH; Olson J; Robertson JT; Barnett GH; Bloomfield S; Albright R; Hochberg FH; Hiesiger E; Green S;
Neurosurgery; 2002 Aug; 51(2):343-55; discussion 355-7. PubMed ID: 12182772
[TBL] [Abstract][Full Text] [Related]
5. Increased tumor cures using combined radiosurgery and BCNU in the treatment of 9l glioma in the rat brain.
Khil MS; Kolozsvary A; Apple M; Kim JH
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):511-6. PubMed ID: 10802380
[TBL] [Abstract][Full Text] [Related]
6. Bax expressed from a herpes viral vector enhances the efficacy of N,N'-bis(2-hydroxyethyl)-N-nitrosourea treatment in a rat glioma model.
Lee A; DeJong G; Guo J; Bu X; Jia WW
Cancer Gene Ther; 2000 Aug; 7(8):1113-9. PubMed ID: 10975671
[TBL] [Abstract][Full Text] [Related]
7. Predicting and monitoring response to chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea in subcutaneously implanted 9L glioma using the apparent diffusion coefficient of water and 23Na MRI.
Babsky AM; Hekmatyar SK; Zhang H; Solomon JL; Bansal N
J Magn Reson Imaging; 2006 Jul; 24(1):132-9. PubMed ID: 16758478
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of a magnetic nanoparticle-based delivery system for BCNU in the treatment of gliomas.
Hua MY; Liu HL; Yang HW; Chen PY; Tsai RY; Huang CY; Tseng IC; Lyu LA; Ma CC; Tang HJ; Yen TC; Wei KC
Biomaterials; 2011 Jan; 32(2):516-27. PubMed ID: 21030073
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study.
Kitamura I; Kochi M; Matsumoto Y; Ueoka R; Kuratsu J; Ushio Y
Cancer Res; 1996 Sep; 56(17):3986-92. PubMed ID: 8752168
[TBL] [Abstract][Full Text] [Related]
10. In vivo enhanced antitumor activity of carmustine [N,N'-bis(2-chloroethyl)-N-nitrosourea] by simvastatin.
Soma MR; Baetta R; De Renzis MR; Mazzini G; Davegna C; Magrassi L; Butti G; Pezzotta S; Paoletti R; Fumagalli R
Cancer Res; 1995 Feb; 55(3):597-602. PubMed ID: 7834630
[TBL] [Abstract][Full Text] [Related]
11. Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment.
Liu HL; Hua MY; Chen PY; Chu PC; Pan CH; Yang HW; Huang CY; Wang JJ; Yen TC; Wei KC
Radiology; 2010 May; 255(2):415-25. PubMed ID: 20413754
[TBL] [Abstract][Full Text] [Related]
12. Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment.
Ting CY; Fan CH; Liu HL; Huang CY; Hsieh HY; Yen TC; Wei KC; Yeh CK
Biomaterials; 2012 Jan; 33(2):704-12. PubMed ID: 22019122
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of gamma knife radiosurgery in the salvage treatment of patients with recurrent high-grade glioma.
Elaimy AL; Mackay AR; Lamoreaux WT; Demakas JJ; Fairbanks RK; Cooke BS; Lamm AF; Lee CM
World Neurosurg; 2013 Dec; 80(6):872-8. PubMed ID: 23403349
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea and low dose rate radiation in the 9L rat brain tumor and spheroid models: implications for brain tumor brachytherapy.
Gutin PH; Bernstein M; Sano Y; Deen DF
Neurosurgery; 1984 Dec; 15(6):781-6. PubMed ID: 6514150
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of C6 glioma in vivo by combination chemotherapy of implantation of polymer wafer and intracarotid perfusion of transferrin-decorated nanoparticles.
Han L; Ren Y; Long L; Zhong Y; Shen C; Pu P; Yuan X; Kang C
Oncol Rep; 2012 Jan; 27(1):121-8. PubMed ID: 21922149
[TBL] [Abstract][Full Text] [Related]
16. Injection of chemotherapeutic microspheres and glioma. IV: Eradicating tumors in rats.
Emerich DF; Winn SR; Bartus RT
Cell Transplant; 2002; 11(1):47-54. PubMed ID: 12095219
[TBL] [Abstract][Full Text] [Related]
17. Combined growth-inhibitory responses and ultrastructural alterations produced by 1,3-bis(2-chloroethyl)-1-nitrosourea and dexamethasone in rat glioma cell cultures.
Grasso RJ; Johnson CE; Boler RK; Moore NA
Cancer Res; 1977 Feb; 37(2):585-94. PubMed ID: 832280
[TBL] [Abstract][Full Text] [Related]
18. Increased survival using delayed gamma knife radiosurgery for recurrent high-grade glioma: a feasibility study.
Dodoo E; Huffmann B; Peredo I; Grinaker H; Sinclair G; Machinis T; Enger PO; Skeie BS; Pedersen PH; Ohlsson M; Orrego A; Kraepelien T; Barsoum P; Benmakhlouf H; Herrman L; Svensson M; Lippitz B
World Neurosurg; 2014 Nov; 82(5):e623-32. PubMed ID: 24930898
[TBL] [Abstract][Full Text] [Related]
19. [An experimental research on the combination treatment of sFLK-1 gene therapy combined with gamma knife].
Chen J; Wang ZR; Li H; Wei YQ; Wang W; Zhu B
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):708-11, 716. PubMed ID: 17037733
[TBL] [Abstract][Full Text] [Related]
20. Gamma knife radiosurgery for central neurocytoma: retrospective analysis of fourteen cases with a median follow-up period of sixty-five months.
Chen MC; Pan DH; Chung WY; Liu KD; Yen YS; Chen MT; Wong TT; Shih YH; Wu HM; Guo WY; Shiau CY; Wang LW; Lin CW
Stereotact Funct Neurosurg; 2011; 89(3):185-93. PubMed ID: 21546789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
